LOCALLY ADVANCED RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to save esophagus in advanced cancer patients
Disease control Recruiting nowThis study tests whether combining the immunotherapy drug camrelizumab with chemotherapy and radiation can shrink advanced esophageal cancer enough to avoid surgery. About 164 patients with stage II to IVa esophageal squamous cell carcinoma will receive one of two drug combinatio…
Matched conditions: LOCALLY ADVANCED RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study tests whether adding the drug adebrelimab to standard chemotherapy before surgery can help eliminate or shrink esophageal cancer more effectively. About 25 people with stage II/III esophageal squamous cell carcinoma will receive the combination, then have surgery. Rese…
Matched conditions: LOCALLY ADVANCED RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: The Second Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC